{"content":"<li class=\"n-box-item date-title\" data-end=\"1481691599\" data-start=\"1481605200\" data-txt=\"Sunday, December 22, 2019\">Tuesday, December 13, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3230427\" data-ts=\"1481673945\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBF\" target=\"_blank\">PBF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230427-pbf-energy-to-launch-10m-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PBF Energy to launch 10M-share offering</a></h4><ul>\n<li>PBF Energy (NYSE:<a href=\"https://seekingalpha.com/symbol/PBF\" title=\"PBF Energy\">PBF</a>) <font color=\"red\">-3%</font> AH after announcing a public offering of 10M common shares, with an underwriters option to purchase up to an additional 1.5M shares.</li>\n<li>PBF says it plans to use the proceeds for general corporate   purposes, including debt repayment, working capital,  capital  expenditures and potential acquisitions.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230427\" data-linked=\"PBF Energy to launch 10M-share offering\" data-tweet=\"$PBF - PBF Energy to launch 10M-share offering https://seekingalpha.com/news/3230427-pbf-energy-to-launch-10m-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3230427-pbf-energy-to-launch-10m-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230425\" data-ts=\"1481673053\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNJ\" target=\"_blank\">JNJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230425-johnson-johnson-backs-away-from-actelion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Johnson &amp; Johnson backs away from Actelion</a></h4><ul>\n<li>Johnson &amp; Johnson (NYSE:<a href=\"https://seekingalpha.com/symbol/JNJ\" title=\"Johnson &amp; Johnson\">JNJ</a>) has reportedly ended its negotiations with Actelion Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ALIOF\" title=\"Actelion Ltd.\">OTCPK:ALIOF</a>) about a possible merger. J&amp;J had made a $20B ($250/share) for the Basel, Switzerland-based biopharma firm, up from its original offer of $17B after Actelion resisted.</li>\n<li>Sanofi (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SNY\" title=\"Sanofi\">SNY</a>) is reportedly mulling a bid as well.</li>\n<li>\n<strong>Update</strong>: In a statement, J&amp;J says its was unable to reach an agreement that it believed would \"create adequate value\" for its shareholders.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230425\" data-linked=\"Johnson &amp; Johnson backs away from Actelion\" data-tweet=\"$JNJ $JNJ $ALIOF - Johnson &amp; Johnson backs away from Actelion https://seekingalpha.com/news/3230425-johnson-johnson-backs-away-from-actelion?source=tweet\" data-url=\"https://seekingalpha.com/news/3230425-johnson-johnson-backs-away-from-actelion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230424\" data-ts=\"1481672613\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VCEL\" target=\"_blank\">VCEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230424-fda-oks-vericels-autologous-cell-therapy-for-cartilage-repair-in-knee-shares-ahead-48-after\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Vericel&#39;s autologous cell therapy for cartilage repair in the knee; shares ahead 48% after hours</a></h4><ul>\n<li>Thinly traded nano cap Vericel (NASDAQ:<a href=\"https://seekingalpha.com/symbol/VCEL\" title=\"Vericel Corporation\">VCEL</a>) is up <font color=\"green\">48%</font> after hours on robust volume in response to the <a href=\"http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm533153.htm\" target=\"_blank\">FDA approval</a> of Maci (<a href=\"https://vcel.com/research-and-development/#AutologuousCellTherapies\" target=\"_blank\">autologous cultured chondrocytes</a> on porcine collagen membrane) for the repair of symptomatic full-thickness cartilage defects of the knee in adult patients.</li>\n<li>\n<a href=\"https://vcel.com/research-and-development/Maci/\" target=\"_blank\">Maci </a>consists of a patient's own (autologous) cells that are expanded in the laboratory and placed onto a bio-resorbable (can be broken down in the body) porcine-derived collagen membrane. The engineered tissue is then surgically placed over the damaged/defective area. Multiple implants can be used if there is more than one defect.</li>\n<li>It is the first product that uses the process of tissue engineering to grow cartilage cells on a scaffold to gain FDA approval.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230424\" data-linked=\"FDA OKs Vericel&#39;s autologous cell therapy for cartilage repair in the knee; shares ahead 48% after hours\" data-tweet=\"$VCEL - FDA OKs Vericel&#39;s autologous cell therapy for cartilage repair in the knee; shares ahead 48% after hours https://seekingalpha.com/news/3230424-fda-oks-vericels-autologous-cell-therapy-for-cartilage-repair-in-knee-shares-ahead-48-after?source=tweet\" data-url=\"https://seekingalpha.com/news/3230424-fda-oks-vericels-autologous-cell-therapy-for-cartilage-repair-in-knee-shares-ahead-48-after\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230420\" data-ts=\"1481671345\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENT\" target=\"_blank\">ENT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230420-global-eagle-up-20-on-extension-of-southwest-airlines-contract\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Global Eagle up 20% on extension of Southwest Airlines contract</a></h4><ul>   <li>Global Eagle Entertainment (<a href=\"https://seekingalpha.com/symbol/ENT\" title=\"Global Eagle Entertainment, Inc.\">ENT</a> <font color=\"green\">+1.7%</font>), <font color=\"green\">up 20%</font> after hours, has entered into a <a href=\"https://seekingalpha.com/filing/3323472\" target=\"_blank\">new deal with Southwest Airlines</a> that runs through the end of 2025.</li>    <li>In a filing, the company notes that deal includes a full-term commitment for live TV service as well as a transition in the middle of next year to a monthly recurring charge per aircraft for Wi-Fi and TV service.</li>    <li>There's an additional rate card for ancillary services provided, Global Eagle says. The company has agreed on terms for a major transponder purchase to support Southwest.</li>    <li>The company's hosting a webcast to discuss <a href=\"https://seekingalpha.com/filing/3323944\" target=\"_blank\">details of the deal</a> tomorrow at 8:30 a.m. ET.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3230420\" data-linked=\"Global Eagle up 20% on extension of Southwest Airlines contract\" data-tweet=\"$ENT - Global Eagle up 20% on extension of Southwest Airlines contract https://seekingalpha.com/news/3230420-global-eagle-up-20-on-extension-of-southwest-airlines-contract?source=tweet\" data-url=\"https://seekingalpha.com/news/3230420-global-eagle-up-20-on-extension-of-southwest-airlines-contract\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230419\" data-ts=\"1481670696\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGLE\" target=\"_blank\">EGLE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230419-eagle-bulk-shipping-launches-100m-private-placement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eagle Bulk Shipping launches $100M private placement</a></h4><ul>     <li>Eagle Bulk Shipping (NASDAQ:<a href=\"https://seekingalpha.com/symbol/EGLE\" title=\"Eagle Bulk Shipping Inc.\">EGLE</a>) <font color=\"red\">-6.4%</font> AH after announcing a private placement of ~22.2M common shares at $4.50/share.</li>\n<li>EGLE says gross proceeds will total $100M, to be used  for the acquisition of dry bulk vessels and general corporate purposes.</li>\n<li>EGLE's board will hold a special meeting of shareholders to approve the placement.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230419\" data-linked=\"Eagle Bulk Shipping launches $100M private placement\" data-tweet=\"$EGLE - Eagle Bulk Shipping launches $100M private placement https://seekingalpha.com/news/3230419-eagle-bulk-shipping-launches-100m-private-placement?source=tweet\" data-url=\"https://seekingalpha.com/news/3230419-eagle-bulk-shipping-launches-100m-private-placement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230418\" data-ts=\"1481670401\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230418-football-drives-another-ratings-win-for-nbc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Football drives another ratings win for NBC</a></h4><ul>   <li>NBC (<a href=\"https://seekingalpha.com/symbol/CMCSA\" title=\"Comcast Corporation\">CMCSA</a> <font color=\"green\">+1.4%</font>) <a href=\"http://abcnews.go.com/Entertainment/wireStory/football-us-nbc-nielsen-win-44171439\" target=\"_blank\">rode football to another win</a> in the Nielsen ratings this week, with NFL programming taking up the top three programs and leading the Peacock past CBS.</li>    <li>NBC drew 10.61M viewers on average for prime time, to 7.76M for CBS (<a href=\"https://seekingalpha.com/symbol/CBS\" title=\"CBS Corporation\">CBS</a> <font color=\"green\">+1.5%</font>). Fox (<a href=\"https://seekingalpha.com/symbol/FOX\" title=\"Twenty-First Century Fox, Inc.\">FOX</a> <font color=\"green\">+2.7%</font>, <a href=\"https://seekingalpha.com/symbol/FOXA\" title=\"Twenty-First Century Fox, Inc.\">FOXA</a> <font color=\"green\">+2.7%</font>) and ABC (<a href=\"https://seekingalpha.com/symbol/DIS\" title=\"The Walt Disney Company\">DIS</a> <font color=\"red\">-0.2%</font>) tied with 4.49M each.</li>    <li>On cable, Fox News ruled again with 2.51M prime-time viewers on average, ahead of Hallmark's 2.27M (it is the holiday season) and ESPN's 2.22M. And NBC prevailed among evening news, averaging 9.18M viewers to ABC's 9.11M.</li>    <li>In <a href=\"http://abcnews.go.com/Entertainment/wireStory/nielsens-top-programs-dec-11-44171203\" target=\"_blank\">top individual programs</a>, NBC's Dallas-New York and Oakland-Kansas City NFL games were first and third with 26.5M and 17.4M viewers respectively, and the network's Sunday pre-kick show was No. 2 with 19M. Rounding out the top five were <i>NCIS</i> on CBS (14.69M) and <i>Football Night in America</i> on NBC (12.91M).</li>    <li>Among cable shows, the half-season mark of <i>The Walking Dead</i> (<a href=\"https://seekingalpha.com/symbol/AMCX\" title=\"AMC Networks Inc.\">AMCX</a> <font color=\"green\">+1%</font>) settled into 11th place with 10.59M viewers.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3230418\" data-linked=\"Football drives another ratings win for NBC\" data-tweet=\"$FOX $FOX $FOXA - Football drives another ratings win for NBC https://seekingalpha.com/news/3230418-football-drives-another-ratings-win-for-nbc?source=tweet\" data-url=\"https://seekingalpha.com/news/3230418-football-drives-another-ratings-win-for-nbc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230405\" data-ts=\"1481667935\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230405-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul><li><b>Top gainers, as of 5.25 p.m.:</b>&nbsp;<a href='https://seekingalpha.com/symbol/NDSN' title='Nordson Corporation'>NDSN</a>&nbsp;<font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/DSX' title='Diana Shipping, Inc.'>DSX</a>&nbsp;<font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/SGYP' title='Synergy Pharmaceuticals, Inc.'>SGYP</a>&nbsp;<font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/GLF' title='GulfMark Offshore, Inc.'>GLF</a>&nbsp;<font color='green'>+4%</font>. <a href='https://seekingalpha.com/symbol/RICK' title='RCI Hospitality Holdings, Inc.'>RICK</a>&nbsp;<font color='green'>+4%</font>.</li><li><b>Top losers, as of 5.25 p.m.:</b>&nbsp;<a href='https://seekingalpha.com/symbol/EGLE' title='Eagle Bulk Shipping Inc.'>EGLE</a>&nbsp;<font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/CPE' title='Callon Petroleum Co.'>CPE</a>&nbsp;<font color='red'>-2%</font>. <a href='https://seekingalpha.com/symbol/ABM' title='ABM Industries Incorporated'>ABM</a>&nbsp;<font color='red'>-2%</font>. <a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a>&nbsp;<font color='red'>-2%</font>. <a href='https://seekingalpha.com/symbol/SIRI' title='Sirius XM Holdings Inc.'>SIRI</a>&nbsp;<font color='red'>-1%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3230405\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$NDSN $DSX $SGYP-OLD - After Hours Gainers / Losers https://seekingalpha.com/news/3230405-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3230405-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230406\" data-ts=\"1481667621\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTZ\" target=\"_blank\">HTZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230406-hertz-names-marinello-new-president-ceo-icahn-approves\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hertz names Marinello as new president/CEO; Icahn approves</a></h4><ul>   <li>Hertz Global Holdings (<a href=\"https://seekingalpha.com/symbol/HTZ\" title=\"Hertz Global Holdings, Inc.\">HTZ</a> <font color=\"green\">+10.6%</font>) has tapped Kathryn Marinello as its new president and CEO, effective Jan. 3, earning an \"excited\" reaction from the company's biggest shareholder, Carl Icahn.</li>    <li>John Tague will retire from those positions the day before.</li>    <li>Shares are <font color=\"red\">3.3% lower</font> after hours.</li>    <li>\"I am excited about Hertz and its prospects with Kathy at the helm,\" Icahn said in a statement. \"Kathy has a history as a proven CEO and I believe she is the right person to lead Hertz as we move forward. Her consistent track record of successes in consumer and financial services, as well as technology businesses, is impressive. She was extremely well-regarded at GE and successfully turned around Ceridian and Stream.\"</li>    <li>Marinello served in a number of leadership roles at General Electric and was CEO of Ceridian Corp. from 2006-2010, and chairman, president and CEO of Stream Global Services from 2010-2014. She's since served as senior adviser of Ares Management.</li>    <li>In addition, the company's three longest-serving directors will leave the boards of Hertz Global Holdings and Hertz Corp. on Jan. 2. After Linda Fayne Levinson (non-executive chair), Carl Berquist and Michael Durham leave their seats, the boards will have seven directors, six of them independent.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3230279-hertz-spikes-icahn-rumor\" target=\"_blank\">Hertz spikes off of Icahn rumor</a> (Dec. 13 2016)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3230406\" data-linked=\"Hertz names Marinello as new president/CEO; Icahn approves\" data-tweet=\"$HTZ - Hertz names Marinello as new president/CEO; Icahn approves https://seekingalpha.com/news/3230406-hertz-names-marinello-new-president-ceo-icahn-approves?source=tweet\" data-url=\"https://seekingalpha.com/news/3230406-hertz-names-marinello-new-president-ceo-icahn-approves\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230404\" data-ts=\"1481667455\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPE\" target=\"_blank\">CPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230404-callon-petroleum-to-buy-delaware-basin-acreage-for-615m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Callon Petroleum to buy Delaware Basin acreage for $615M</a></h4><ul>     <li>Callon Petroleum (NYSE:<a href=\"https://seekingalpha.com/symbol/CPE\" title=\"Callon Petroleum Co.\">CPE</a>) <font color=\"red\">-2.8%</font> AH after agreeing to acquire undeveloped acreage and producing oil and gas properties in west Texas from American Resource Development for $615M.</li>     <li>The deal marks CPE's initial entry into the Delaware Basin, with properties currently producing 1,945 boe/day (71% oil), including production from 20 gross operated horizontal wells producing from the Wolfcamp and Bone Spring formations.</li>     <li>To help fund the deal, CPE launches a 34M-share public offering, with an underwriters option to purchase up to an additional 5.1M common shares.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3230404\" data-linked=\"Callon Petroleum to buy Delaware Basin acreage for $615M\" data-tweet=\"$CPE - Callon Petroleum to buy Delaware Basin acreage for $615M https://seekingalpha.com/news/3230404-callon-petroleum-to-buy-delaware-basin-acreage-for-615m?source=tweet\" data-url=\"https://seekingalpha.com/news/3230404-callon-petroleum-to-buy-delaware-basin-acreage-for-615m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230388\" data-ts=\"1481664946\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NDSN\" target=\"_blank\">NDSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230388-nordson-beats-0_15-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nordson beats by $0.15, beats on revenue</a></h4><ul>\n<li>Nordson (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NDSN\" title=\"Nordson Corporation\">NDSN</a>): FQ4 EPS of $1.39 <font color=\"green\">beats by $0.15</font>.</li>\n<li>Revenue of $509M (+14.1% Y/Y) <font color=\"green\">beats by $26.91M</font>.</li>\n<li>Shares <font color=\"green\">+3.3%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230388\" data-linked=\"Nordson beats by $0.15, beats on revenue\" data-tweet=\"$NDSN - Nordson beats by $0.15, beats on revenue https://seekingalpha.com/news/3230388-nordson-beats-0_15-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3230388-nordson-beats-0_15-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230376\" data-ts=\"1481664104\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HEI\" target=\"_blank\">HEI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230376-heico-beats-0_03-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HEICO beats by $0.03, misses on revenue</a></h4><ul>\n<li>HEICO (NYSE:<a href=\"https://seekingalpha.com/symbol/HEI\" title=\"HEICO Corporation\">HEI</a>): FQ4 EPS of $0.65 <font color=\"green\">beats by $0.03</font>.</li>\n<li>Revenue of $363.3M (+10.5% Y/Y) <font color=\"red\">misses by $9.36M</font>.</li>\n<li>Shares <font color=\"green\">+2.6%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230376\" data-linked=\"HEICO beats by $0.03, misses on revenue\" data-tweet=\"$HEI - HEICO beats by $0.03, misses on revenue https://seekingalpha.com/news/3230376-heico-beats-0_03-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3230376-heico-beats-0_03-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230369\" data-ts=\"1481663696\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNOB\" target=\"_blank\">CNOB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230369-another-bank-secondary\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Another bank secondary</a></h4><ul>\n<li>The capital raises from banks are coming at a furious pace, with the latest from ConnectOne Bancorp (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CNOB\" title=\"ConnectOne Bancorp\">CNOB</a>). It's offering $35M worth of stock, or $40.25M if the underwriters exercise their greenshoe.</li>\n<li>CNOB is <font color=\"green\">up 38%</font> YTD, with nearly the entirely of that gain coming since early November.</li>\n<li>Shares <font color=\"red\">-1%</font> after hours.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230369\" data-linked=\"Another bank secondary\" data-tweet=\"$CNOB - Another bank secondary https://seekingalpha.com/news/3230369-another-bank-secondary?source=tweet\" data-url=\"https://seekingalpha.com/news/3230369-another-bank-secondary\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230361\" data-ts=\"1481663121\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YELP\" target=\"_blank\">YELP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230361-yelpplus-2_1-aegis-launches-coverage-buy-on-margin-expansion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yelp +2.1% as Aegis launches coverage at Buy on margin expansion</a></h4><ul>   <li>Yelp (NYSE:<a href=\"https://seekingalpha.com/symbol/YELP\" title=\"Yelp\">YELP</a>) closed <font color=\"green\">up 2.1%</font> today after a launch at Buy from Aegis Capital.</li>    <li>The company is pursuing new product opportunities to expand its margins, writes the firm's Victor Anthony. He has a price target of $47, implying 31% upside from today's price.</li>    <li>Most analysts are evenly split between Buy and Hold ratings on the shares. Last week, Macquarie reiterated its Outperform rating (and price target of $49); after earnings last month, Baird and Needham took the opportunity to boost price targets (to $40 and $43 respectively).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3230361\" data-linked=\"Yelp +2.1% as Aegis launches coverage at Buy on margin expansion\" data-tweet=\"$YELP - Yelp +2.1% as Aegis launches coverage at Buy on margin expansion https://seekingalpha.com/news/3230361-yelpplus-2_1-aegis-launches-coverage-buy-on-margin-expansion?source=tweet\" data-url=\"https://seekingalpha.com/news/3230361-yelpplus-2_1-aegis-launches-coverage-buy-on-margin-expansion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230348\" data-ts=\"1481661519\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IHRTQ\" target=\"_blank\">IHRTQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230348-iheartmedia-leaving-57m-in-notes-held-clear-channel-on-books\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IHeartMedia leaving $57M in notes held by Clear Channel on books</a></h4><ul>   <li>Amid a capital restructuring, iHeartMedia (<a href=\"https://seekingalpha.com/symbol/IHRT\" target=\"_blank\">IHRT</a> <font color=\"green\">+4%</font>) has decided not to repay $57.1M of 5.5% senior notes held by its affiliate Clear Channel Holdings that are due on Thursday, and filed a lawsuit in connection with that move.</li>    <li>Another $192.9M of the notes held by others will be paid in full -- but keeping the $57.1M on the books frees iHeartMedia from an obligation to grant some security interests in favor of some of its debtholders (via a so-called \"springing lien\").</li>    <li>The company's lawsuit is seeking a declaration that those notes remain outstanding and that the company doesn't have to grant the \"springing lien\" on any assets.</li>    <li>It's been <a href=\"https://seekingalpha.com/news/3185289-iheartmedia-wins-ruling-stock-transfer-case-creditors\" target=\"_blank\">engaged in disputes this year</a> with creditors over stock-transfer moves among its affiliates.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3230348\" data-linked=\"IHeartMedia leaving $57M in notes held by Clear Channel on books\" data-tweet=\"$IHRTQ $IHRT - IHeartMedia leaving $57M in notes held by Clear Channel on books https://seekingalpha.com/news/3230348-iheartmedia-leaving-57m-in-notes-held-clear-channel-on-books?source=tweet\" data-url=\"https://seekingalpha.com/news/3230348-iheartmedia-leaving-57m-in-notes-held-clear-channel-on-books\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230344\" data-ts=\"1481661045\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230344-technology-top-5-gainers-losers-of-3-30-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:30 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/INVE' title='Identiv, Inc.'>INVE</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/IDN' title='Intellicheck Mobilisa, Inc.'>IDN</a> <font color='green'>+12%</font>.<a href='https://seekingalpha.com/symbol/WTT' title='Wireless Telecom Group, Inc'>WTT</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/ASUR' title='Asure Software, Inc.'>ASUR</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/INOV' title='Inovalon'>INOV</a> <font color='red'>-36%</font>. <a href='https://seekingalpha.com/symbol/MODN' title='Model N'>MODN</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/VHC' title='VirnetX Holding Corporation'>VHC</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/AVID' title='Avid Technology, Inc.'>AVID</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3230344\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:30 PM\" data-tweet=\"$INVE $IDN $WTT - Technology - Top 5 Gainers / Losers as of 3:30 PM https://seekingalpha.com/news/3230344-technology-top-5-gainers-losers-of-3-30-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3230344-technology-top-5-gainers-losers-of-3-30-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230345\" data-ts=\"1481660859\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230345-mega-cap-tech-trading-hot\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mega-cap tech trading hot</a></h4><ul>\n<li>Apple (<a href=\"https://seekingalpha.com/symbol/AAPL\" title=\"Apple Inc.\">AAPL</a> <font color=\"green\">+2.2%</font>), Amazon (<a href=\"https://seekingalpha.com/symbol/AMZN\" title=\"Amazon.com, Inc.\">AMZN</a> <font color=\"green\">+2.4%</font>), Microsoft (<a href=\"https://seekingalpha.com/symbol/MSFT\" title=\"Microsoft Corporation\">MSFT</a> <font color=\"green\">+1.6%</font>), Alphabet (<a href=\"https://seekingalpha.com/symbol/GOOG/focus\" target=\"_blank\">GOOG</a>, <a href=\"https://seekingalpha.com/symbol/GOOGL/focus\" target=\"_blank\">GOOGL</a>) and Facebook (<a href=\"https://seekingalpha.com/symbol/FB\" title=\"Facebook\">FB</a> <font color=\"green\">+2.5%</font>) are continuing to elevate through December, at this point respectively higher by <font color=\"green\">9.4%</font>, <font color=\"green\">8.2%</font>, <font color=\"green\">8.8%</font>, <font color=\"green\">8.8%/9%</font> and <font color=\"green\">4.8%</font> on a 1-month term (November 14).</li>\n<li>Not the only movers in the space, high-profile companies ranging from IBM and Intel to Qualcomm, Oracle and others are also on strong momentum, with many names having fully recovered from a <a href=\"https://seekingalpha.com/news/3228016-broad-sell-strikes-tech\" target=\"_blank\">widespread sell-off</a> briefly overcoming the sector earlier this month.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230345\" data-linked=\"Mega-cap tech trading hot\" data-tweet=\"$AAPL $AAPL $AMZN - Mega-cap tech trading hot https://seekingalpha.com/news/3230345-mega-cap-tech-trading-hot?source=tweet\" data-url=\"https://seekingalpha.com/news/3230345-mega-cap-tech-trading-hot\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>66&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230341\" data-ts=\"1481660442\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATW\" target=\"_blank\">ATW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230341-atwood-rowan-among-oil-services-stocks-primed-for-takeout-analyst-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Atwood, Rowan among oil services stocks primed for takeout, analyst says</a></h4><ul>\n<li>Offshore drillers Atwood Oceanics (<a href=\"https://seekingalpha.com/symbol/ATW\" title=\"Atwood Oceanics Inc.\">ATW</a> <font color=\"green\">+1.9%</font>) and Rowan (<a href=\"https://seekingalpha.com/symbol/RDC\" title=\"Rowan Companies plc\">RDC</a> <font color=\"green\">+0.3%</font>), as well as Oceaneering International (<a href=\"https://seekingalpha.com/symbol/OII\" title=\"Oceaneering International Inc.\">OII</a> <font color=\"green\">+3.1%</font>), Helix Energy Solutions (<a href=\"https://seekingalpha.com/symbol/HLX\" title=\"Helix Energy Solutions Group, Inc.\">HLX</a> <font color=\"green\">+0.3%</font>) and Flotek Industries (<a href=\"https://seekingalpha.com/symbol/FTK\" title=\"Flotek Industries, Inc.\">FTK</a> <font color=\"red\">-2.9%</font>) are the <a href=\"http://blogs.barrons.com/stockstowatchtoday/2016/12/13/2-offshore-drillers-ripe-for-a-takeout/\" target=\"_blank\">favorite takeout candidates</a> among oilfield services stocks for Stephens analyst Matthew Marietta.</li>\n<li>As Marietta says today's Patterson-UTI (<a href=\"https://seekingalpha.com/symbol/PTEN\" title=\"Patterson-UTI Energy, Inc.\">PTEN</a> <font color=\"red\">-7.3%</font>) \"<a href=\"https://seekingalpha.com/news/3230186-patterson-uti-buy-seventy-seven-energy-1_76b-deal\" target=\"_blank\">well-priced takeout</a>\" of Seventy Seven Energy attests, the firm believes M&amp;A in the sector will remain prevalent and continues to see deal-flow potential in well-capitalized companies with technology differentiation or top tier asset quality.</li>\n<li>Marietta believes confidence is becoming restored in oilfield services company management teams and that the potential accelerates for the IPO market to heat up.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230341\" data-linked=\"Atwood, Rowan among oil services stocks primed for takeout, analyst says\" data-tweet=\"$ATW $ATW $RDC - Atwood, Rowan among oil services stocks primed for takeout, analyst says https://seekingalpha.com/news/3230341-atwood-rowan-among-oil-services-stocks-primed-for-takeout-analyst-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3230341-atwood-rowan-among-oil-services-stocks-primed-for-takeout-analyst-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230335\" data-ts=\"1481658343\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NSM\" target=\"_blank\">NSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230335-challenging-outlook-for-mortgage-banks-kbw\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Challenging outlook for mortgage banks - KBW</a></h4><ul>\n<li>KBW has ratcheted up its baseline projection for rates hikes - now seeing five through 2018 vs. a just one previously. That means slowing mortgage origination activity - $1.55T estimated for next year vs. $1.83T previously.</li>\n<li>It's not all bad for specialty servicers like Nationstar Mortgage (<a href=\"https://seekingalpha.com/symbol/NSM\" title=\"Nationstar Mortgage Holdings\">NSM</a> <font color=\"red\">-0.5%</font>), which can offset weaker mortgage banking profitability with lower prepays on its servicing portfolio. Analyst Bose George, however, does cut Walter Investment (WAC <font color=\"red\">-10.6%</font>) to Underperform from Market Perform.</li>\n<li>Though pricey, mortgage insurers are well positioned to grow earnings, and George lifts estimates for industry-wide insurance in force growth to 7% from 5%, and cites Essent Group (<a href=\"https://seekingalpha.com/symbol/ESNT\" title=\"Essent Group Ltd.\">ESNT</a> <font color=\"red\">-4.1%</font>) and NMI Holdings (<a href=\"https://seekingalpha.com/symbol/NMIH\" title=\"NMI Holdings, Inc.\">NMIH</a> <font color=\"red\">-0.5%</font>).</li>\n<li>Lower refi volumes are likely to hurt title insurers , but growth in the purchase market should partially offset. He keeps Fidelity National (<a href=\"https://seekingalpha.com/symbol/FNF\" title=\"Fidelity National Financial Inc.\">FNF</a> <font color=\"red\">-0.2%</font>) and First American (<a href=\"https://seekingalpha.com/symbol/FAF\" title=\"First American Financial Corporation\">FAF</a> <font color=\"green\">+0.8%</font>) at Market Perform, but cuts Stewart Information (<a href=\"https://seekingalpha.com/symbol/STC\" title=\"Stewart Information Services Corporation\">STC</a> <font color=\"red\">-5.4%</font>) to Underperform on valuation.</li>\n<li>Source: Bloomberg</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3230330-rough-session-mreits-bull-turns-cautious\" target=\"_blank\">Rough session for mREITs as bull turns cautious</a> (Dec. 13)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230335\" data-linked=\"Challenging outlook for mortgage banks - KBW\" data-tweet=\"$NSM $NSM $DHCP - Challenging outlook for mortgage banks - KBW https://seekingalpha.com/news/3230335-challenging-outlook-for-mortgage-banks-kbw?source=tweet\" data-url=\"https://seekingalpha.com/news/3230335-challenging-outlook-for-mortgage-banks-kbw\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230334\" data-ts=\"1481657920\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOL\" target=\"_blank\">GOL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230334-gol-linhas-rallies-after-load-factor-moves-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gol Linhas rallies after load factor moves higher</a></h4><ul> <li>Gol Linhas (<a href=\"https://seekingalpha.com/symbol/GOL\" title=\"GOL Linhas Aéreas Inteligentes S.A.\">GOL</a> <font color=\"green\">+3.3%</font>) trades higher after reporting a huge improvement in load factor for November.</li> <li>Load factor improved 460 bps to 77.8% after revenue miles outpaced capacity growth (domestic ASKs -5%, international ASKs -17%) during the month.</li> <li>Shares of Gol Linhas are <font color=\"green\">up 3.41%</font> to $13.63 vs. a 52-week trading range of $2.43 to $27.08.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3230334\" data-linked=\"Gol Linhas rallies after load factor moves higher\" data-tweet=\"$GOL - Gol Linhas rallies after load factor moves higher https://seekingalpha.com/news/3230334-gol-linhas-rallies-after-load-factor-moves-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3230334-gol-linhas-rallies-after-load-factor-moves-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230331\" data-ts=\"1481656730\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEX\" target=\"_blank\">TEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230331-terex-hits-two-year-high-after-laying-out-restructuring-2020-goals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Terex hits two-year high after laying out restructuring, 2020 goals</a></h4><ul>\n<li>Terex (<a href=\"https://seekingalpha.com/symbol/TEX\" title=\"Terex Corporation\">TEX</a> <font color=\"green\">+7.4%</font>) trades at two-year highs following an Investor Day <a href=\"http://www.terex.com/en/investor-relations/index.htm\" target=\"_blank\">presentation</a> where the company laid out its strategy through 2020.</li>\n<li>TEX sees FY 2017 net sales of ~$4B with a 5% operating margin and $100M-$150M in free cash flow; it sees ~1% organic revenue compound annual growth rate with an operating margin above 10% and return on invested capital above 20% vs, ~6% today.</li>\n<li>In returning capital to shareholders, TEX says it also plans a double digit annual percentage increase in the dividend and $1B-$1.5B in cumulative share repurchases through 2020.</li>\n<li>TEX stock has been a big beneficiary of the Trump trade, up ~40% since the Nov. 8 election and 75% YTD.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230331\" data-linked=\"Terex hits two-year high after laying out restructuring, 2020 goals\" data-tweet=\"$TEX - Terex hits two-year high after laying out restructuring, 2020 goals https://seekingalpha.com/news/3230331-terex-hits-two-year-high-after-laying-out-restructuring-2020-goals?source=tweet\" data-url=\"https://seekingalpha.com/news/3230331-terex-hits-two-year-high-after-laying-out-restructuring-2020-goals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230330\" data-ts=\"1481656109\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYS\" target=\"_blank\">CYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230330-rough-session-for-mreits-bull-turns-cautious\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rough session for mREITs as bull turns cautious</a></h4><ul>\n<li>KBW's Bose George now sees five Fed rate hikes by the end of 2018 vs. his previous estimate of just one. He lowers his sector (<a href=\"https://seekingalpha.com/symbol/REM\" title=\"iShares Mortgage Real Estate Capped ETF\">REM</a> <font color=\"red\">-1.3%</font>) estimates by 4% for 2017 and 2018.</li>\n<li>Downgraded to Market Perform from Outperform are CYS Investments (<a href=\"https://seekingalpha.com/symbol/CYS\" title=\"CYS Investments, Inc.\">CYS</a> <font color=\"red\">-2.5%</font>), and Invesco Mortgage (<a href=\"https://seekingalpha.com/symbol/IVR\" title=\"Invesco Mortgage Capital Inc.\">IVR</a> <font color=\"red\">-3.9%</font>).</li>\n<li>Annaly (<a href=\"https://seekingalpha.com/symbol/NLY\" title=\"Annaly Capital Management, Inc.\">NLY</a> <font color=\"red\">-1.2%</font>), AGNC Investment (<a href=\"https://seekingalpha.com/symbol/AGNC\" title=\"AGNC Investment Corp.\">AGNC</a> <font color=\"red\">-1.1%</font>), MTGE Investment (<a href=\"https://seekingalpha.com/symbol/MTGE\" title=\"MTGE Investment Corp.\">MTGE</a> <font color=\"red\">-2.6%</font>), New York Mortgage (<a href=\"https://seekingalpha.com/symbol/NYMT\" title=\"New York Mortgage Trust, Inc.\">NYMT</a> <font color=\"red\">-2.2%</font>), Capstead (<a href=\"https://seekingalpha.com/symbol/CMO\" title=\"Capstead Mortgage Corporation\">CMO</a> <font color=\"red\">-2.5%</font>), Western Asset (<a href=\"https://seekingalpha.com/symbol/WMC\" title=\"Western Asset Mortgage Capital Corporation\">WMC</a> <font color=\"red\">-2.6%</font>), AG Mortgage (<a href=\"https://seekingalpha.com/symbol/MITT\" title=\"AG Mortgage Investment Trust, Inc.\">MITT</a> <font color=\"red\">-3.3%</font>)</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/MORT\" title=\"VanEck Vectors Mortgage REIT Income ETF\">MORT</a>, <a href=\"https://seekingalpha.com/symbol/MORL\" title=\"UBS ETRACS Monthly Pay 2x Leveraged Mortgage REIT ETN\">MORL</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230330\" data-linked=\"Rough session for mREITs as bull turns cautious\" data-tweet=\"$CYS $REM $CYS - Rough session for mREITs as bull turns cautious https://seekingalpha.com/news/3230330-rough-session-for-mreits-bull-turns-cautious?source=tweet\" data-url=\"https://seekingalpha.com/news/3230330-rough-session-for-mreits-bull-turns-cautious\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>51&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230328\" data-ts=\"1481655802\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230328-energy-materials-top-5-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/USEG' title='U.S. Energy Corp.'>USEG</a> <font color='green'>+45%</font>. <a href='https://seekingalpha.com/symbol/GLF' title='GulfMark Offshore, Inc.'>GLF</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/BCEI' title='Bonanza Creek Energy'>BCEI</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/PTR' title='PetroChina Company Limited'>PTR</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/NADL' title='North Atlantic Drilling Ltd.'>NADL</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/YUMA' title='Yuma Energy, Inc.'>YUMA</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/DELT' title='Delta Technology Holdings Limited'>DELT</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil & Gas, Inc'>NOG</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/NWPX' title='Northwest Pipe Company'>NWPX</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/UEC' title='Uranium Energy Corp'>UEC</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3230328\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm\" data-tweet=\"$USEG $GLF $BCEI - Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3230328-energy-materials-top-5-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3230328-energy-materials-top-5-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230326\" data-ts=\"1481654244\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230326-tesla-motors-revisits-200\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla Motors revisits $200</a></h4><ul> <li>Tesla Motors (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TSLA\" title=\"Tesla, Inc.\">TSLA</a>) <font color=\"green\">jumps 4.08%</font> to jump over $200 for the first time since late October.</li> <li>The biggest news in the automobile industry today is Google's decision to spin off its self-driving car project into a stand-alone company called Waymo.</li> <li>Waymo won't be a manufacturer, but will <a href=\"http://www.nytimes.com/2016/12/13/technology/google-parent-company-spins-off-waymo-self-driving-car-business.html\" target=\"_blank\">focus</a> on the technology side of autonomous driving, including keeping an eye on ride-sharing services and long-haul trucking.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3230175-report-google-scales-back-self-driving-car-ambitions\" target=\"_blank\">Report: Google scales back self-driving car ambitions</a> (Dec. 13)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3230326\" data-linked=\"Tesla Motors revisits $200\" data-tweet=\"$TSLA - Tesla Motors revisits $200 https://seekingalpha.com/news/3230326-tesla-motors-revisits-200?source=tweet\" data-url=\"https://seekingalpha.com/news/3230326-tesla-motors-revisits-200\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>164&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230310\" data-ts=\"1481652648\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LIFE\" target=\"_blank\">LIFE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230310-early-stage-data-on-atyr-pharmas-resolaris-mixed-shares-slump-22\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Early-stage data on aTyr Pharma&#39;s Resolaris mixed; shares slump 22%</a></h4><ul>\n<li>Thinly traded nano cap aTyr Pharma (<a href=\"https://seekingalpha.com/symbol/LIFE\" title=\"aTyr Pharma\">LIFE</a> <font color=\"red\">-21.9%</font>) heads south on a 4x surge in volume, albeit on turnover of only 417K shares, in response to its announcement of results from several early-stage studies assessing lead product candidate Resolaris in adults with limb-girdle muscular dystrophy 2B (LGMD2B) or facioscapulohumeral muscular dystrophy (FSHD), two rare genetic disorders characterized by muscle weakness and wasting.</li>\n<li>Top-line results from the Phase 1b/2 study (004 Trial) showed improvements in muscle strength from baseline in seven of nine patients treated with 3.0 mg/kg of Resolaris twice weekly for 12 weeks, although only one surpassed a 10% improvement (~21%) as measured by manual muscle testing (MMT) scores. Analyses of various biomarkers were not able to establish robust signals of efficacy.</li>\n<li>Interim data from four subjects an ongoing Phase 1b/2 study (003 Trial) in early-onset FSHD patients showed two patients with slight decreases in disease burden and one with an increase as measured by a quality-of-life questionnaire called INQoL.</li>\n<li>Data from another study (002 Trial) showed no significant trends in either MMT or INQoL scores in four patients who received at least six months of therapy.</li>\n<li>The overall discontinuation rate was 31% (n=11/35).</li>\n<li>\n<a href=\"http://www.atyrpharma.com/programs/resolaris/\" target=\"_blank\">Resolaris </a>is an intravenous protein therapeutic derived from naturally occurring protein released by human skeletal muscle cells.</li>\n<li>The company intends to advance development of Resolaris. It also plans to meet with the FDA next year to discuss a regulatory pathway towards a Biologics License Application (BLA).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230310\" data-linked=\"Early-stage data on aTyr Pharma&#39;s Resolaris mixed; shares slump 22%\" data-tweet=\"$LIFE - Early-stage data on aTyr Pharma&#39;s Resolaris mixed; shares slump 22% https://seekingalpha.com/news/3230310-early-stage-data-on-atyr-pharmas-resolaris-mixed-shares-slump-22?source=tweet\" data-url=\"https://seekingalpha.com/news/3230310-early-stage-data-on-atyr-pharmas-resolaris-mixed-shares-slump-22\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230313\" data-ts=\"1481652036\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230313-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LMRK' title='Landmark Infrastructure Partners LP'>LMRK</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/IRET' title='Investors Real Estate Trust'>IRET</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/PN' title='Patriot National, Inc.'>PN</a> <font color='green'>+8%</font>. IFMI <font color='green'>+6%</font>.</li><li><b>Losers:</b> WAC <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/JTPY' title='JetPay Corporation'>JTPY</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/NSA' title='National Storage Affiliates Trust'>NSA</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/SIEB' title='Siebert Financial Corp.'>SIEB</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3230313\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$LMRK $IRET $PN - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3230313-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3230313-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230314\" data-ts=\"1481651906\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIVHY\" target=\"_blank\">VIVHY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230314-mediasetplus-24-vivendi-hints-possible-hostile-pursuit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mediaset +24% as Vivendi hints at possible hostile pursuit</a></h4><ul>   <li>After a contentious year featuring a fight over an aborted TV operations deal, increasingly acquisitive Vivendi (<a href=\"https://seekingalpha.com/symbol/VIVHY\" title=\"Vivendi SA ADR\">OTCPK:VIVHY</a>) says now that it could seek a 20% stake in Mediaset (<a href=\"https://seekingalpha.com/symbol/MDIUY\" title=\"Mediaset S.p.A. ADR\">OTCPK:MDIUY</a> <font color=\"green\">+24.4%</font>) en route to <a href=\"http://www.reuters.com/article/us-mediaset-vivendi-idUSKBN1412SI?feedType=nl&amp;feedName=innovationNews&amp;utm_source=Sailthru&amp;utm_medium=email&amp;utm_campaign=US%20Deals%20Today%202016-12-13&amp;utm_term=US%20Deals%20Today\" target=\"_blank\">launching a hostile takeover</a> of the Italian company.</li>    <li>Vivendi has just over 3% of Mediaset now. In the summer it <a href=\"https://seekingalpha.com/news/3196208-mediaset-shares-fall-vivendi-backs-tv-acquisition-deal\" target=\"_blank\">backed out of a deal</a> to buy Mediaset's pay TV operations, launching a pitched cross-border battle between the two.</li>    <li>\"Vivendi intends to carry on its purchase of shares in Mediaset, depending on market conditions, to become, if possible, the second industrial shareholder in Mediaset, which to begin with could represent 10 to 20% of Mediaset's capital,\" Vivendi said.</li>    <li>\"Vincent Bollore and Vivendi have shown what their true intentions towards Mediaset were from the very start,\" said a statement from Fininvest, the holding company of former Italian prime minister Silvio Berlusconi, which controls Mediaset.</li>    <li>Mediaset's Premium TV business (or the whole company) would represent another piece in a southern Europe strategy for the French media giant, which is also the biggest shareholder at Telecom Italia (<a href=\"https://seekingalpha.com/symbol/TI\" title=\"Telecom Italia S.P.A.\">TI</a> <font color=\"green\">+1.9%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3230314\" data-linked=\"Mediaset +24% as Vivendi hints at possible hostile pursuit\" data-tweet=\"$VIVHY $VIVHY $MDIUY - Mediaset +24% as Vivendi hints at possible hostile pursuit https://seekingalpha.com/news/3230314-mediasetplus-24-vivendi-hints-possible-hostile-pursuit?source=tweet\" data-url=\"https://seekingalpha.com/news/3230314-mediasetplus-24-vivendi-hints-possible-hostile-pursuit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230312\" data-ts=\"1481651526\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230312-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>\n<li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/USEG\" title=\"U.S. Energy Corp.\">USEG</a> <font color=\"green\">+54%</font>. <a href=\"https://seekingalpha.com/symbol/GLF\" title=\"GulfMark Offshore, Inc.\">GLF</a> <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/OPGN\" title=\"OpGen\">OPGN</a> <font color=\"green\">+17%</font>. <a href=\"https://seekingalpha.com/symbol/AKAO\" title=\"Achaogen\">AKAO</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/BCEI\" title=\"Bonanza Creek Energy\">BCEI</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/INVE\" title=\"Identiv, Inc.\">INVE</a> <font color=\"green\">+11%</font>. [[]] <font color=\"green\">+%</font>. <a href=\"https://seekingalpha.com/symbol/IDN\" title=\"Intellicheck Mobilisa, Inc.\">IDN</a> <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/INFU\" title=\"InfuSystem Holdings, Inc.\">INFU</a> <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/NVCN\" title=\"Neovasc Inc.\">NVCN</a> <font color=\"green\">+10%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/PRTO\" title=\"Proteon Therapeutics\">PRTO</a> <font color=\"red\">-73%</font>. <a href=\"https://seekingalpha.com/symbol/INOV\" title=\"Inovalon\">INOV</a> <font color=\"red\">-35%</font>. APRI <font color=\"red\">-22%</font>. <a href=\"https://seekingalpha.com/symbol/LIFE\" title=\"aTyr Pharma\">LIFE</a> <font color=\"red\">-21%</font>. <a href=\"https://seekingalpha.com/symbol/DELT\" title=\"Delta Technology Holdings Limited\">DELT</a> <font color=\"red\">-16%</font>. <a href=\"https://seekingalpha.com/symbol/ATOS\" title=\"Atossa Genetics, Inc.\">ATOS</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/GLBS\" title=\"Globus Maritime Ltd.\">GLBS</a> <font color=\"red\">-12%</font>. <a href=\"https://seekingalpha.com/symbol/LFVN\" title=\"LifeVantage Corporation\">LFVN</a> <font color=\"red\">-11%</font>. PSDV <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/VHC\" title=\"VirnetX Holding Corporation\">VHC</a> <font color=\"red\">-11%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230312\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$USEG $GLF $OPGN - Midday Gainers / Losers https://seekingalpha.com/news/3230312-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3230312-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230308\" data-ts=\"1481650723\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONVO\" target=\"_blank\">ONVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230308-organovo-presents-encouraging-preclinical-survival-and-functionality-data-on-3d-bioprinted\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Organovo presents encouraging preclinical survival and functionality data on 3D bioprinted liver tissue; shares up 9%</a></h4><ul>\n<li>Organovo (<a href=\"https://seekingalpha.com/symbol/ONVO\" title=\"Organovo Holdings, Inc.\">ONVO</a> <font color=\"green\">+8.8%</font>) perks up on double normal volume in apparent response to the release of positive preclinical data on its 3D bioprinted human liver tissue. The results were presented at the TERMIS-Americas Meeting in San Diego.</li>\n<li>Company scientists implanted patches of its 3D human liver tissue onto the livers of <a href=\"http://www.criver.com/products-services/basic-research/find-a-model/nod-scid-mouse\" target=\"_blank\">NOD/SCID mice</a> which have been engineered to have weakened immune systems (ideal model for xenograft research). After 28 days, the tissues remained intact and well tolerated. Analyses of tissue samples revealed the presence of key human metabolic enzymes associated with inborn errors of metabolism.</li>\n<li>Organovo says a bioprinted liver patch has potential to treat acute-on-chronic liver failure and pediatric inborn errors of metabolism. It plans to file an Investigational New Drug (IND) application with the FDA for therapeutic liver tissue in three to five years.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230308\" data-linked=\"Organovo presents encouraging preclinical survival and functionality data on 3D bioprinted liver tissue; shares up 9%\" data-tweet=\"$ONVO - Organovo presents encouraging preclinical survival and functionality data on 3D bioprinted liver tissue; shares up 9% https://seekingalpha.com/news/3230308-organovo-presents-encouraging-preclinical-survival-and-functionality-data-on-3d-bioprinted?source=tweet\" data-url=\"https://seekingalpha.com/news/3230308-organovo-presents-encouraging-preclinical-survival-and-functionality-data-on-3d-bioprinted\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230300\" data-ts=\"1481649566\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPGN\" target=\"_blank\">OPGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230300-opgen-up-big-cant-hold-onto-gain\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Opgen up big but can&#39;t hold onto gain</a></h4><ul>\n<li>Thinly traded nano cap Opgen (<a href=\"https://seekingalpha.com/symbol/OPGN\" title=\"OpGen\">OPGN</a> <font color=\"green\">+20.6%</font>) is up on a colossal 71x surge in volume (over 20M turnover). Shares peaked at $3.10 (+158%) before retracing. No particular news accounts for the extraordinary action.</li>\n<li>The company provides molecular testing services via its CLIA-certified laboratory that are used to identify multi-drug-resistant organisms (MDRO). Its lead offering is the Acuitas MDRO Gene Test that directly detects 10 genes unique to MDRO from swab or clinical isolate samples.</li>\n<li>Last month, the company inked a <a href=\"http://ir.opgen.com/phoenix.zhtml?c=253977&amp;p=irol-newsArticle&amp;ID=2221993\" target=\"_blank\">collaboration </a>with Merck (<a href=\"https://seekingalpha.com/symbol/MRK\" title=\"Merck &amp; Co Inc.\">MRK</a> <font color=\"red\">-0.4%</font>) to develop rapid diagnostics and information technology products to fight the threat of antimicrobial resistance.</li>\n<li>Shares have been in a downtrend since debuting at $6/unit (stock and warrant) in May 2015.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230300\" data-linked=\"Opgen up big but can&#39;t hold onto gain\" data-tweet=\"$OPGN $OPGN $MRK - Opgen up big but can&#39;t hold onto gain https://seekingalpha.com/news/3230300-opgen-up-big-cant-hold-onto-gain?source=tweet\" data-url=\"https://seekingalpha.com/news/3230300-opgen-up-big-cant-hold-onto-gain\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230299\" data-ts=\"1481648386\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230299-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PAY' title='VeriFone Systems, Inc.'>PAY</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/THST' title='Truett-Hurst, Inc.'>THST</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/ZX' title='China Zenix Auto International'>ZX</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/JOUT' title='Johnson Outdoors Inc.'>JOUT</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/LFVN' title='LifeVantage Corporation'>LFVN</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/HOFT' title='Hooker Furniture Corporation'>HOFT</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3230299\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$PAY $THST $ZXAIY - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3230299-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3230299-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230294\" data-ts=\"1481646334\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMG\" target=\"_blank\">CMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230294-reactions-to-chipotles-new-look\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reactions to Chipotle&#39;s new look</a></h4><ul>     <li>Chipotle (<a href=\"https://seekingalpha.com/symbol/CMG\" title=\"Chipotle Mexican Grill, Inc.\">CMG</a> <font color=\"red\">-1.4%</font>) is on the radar of analysts and shareholders after the company reset strategy yesterday.</li>     <li>During a conference call late yesterday, Chipotle CEO Steve Ellis said the running of the company's restaurants has become too complicated. The hiring of a new COO is expected to help set the chain back on the right path.</li>     <li>Shareholder CtW Investment Group sent out a <a href=\"http://www.reuters.com/article/us-chipotle-board-idUSKBN1421RD\" target=\"_blank\">warning shot</a> to Pershing Square Capital Morning (~10% CMG holder) this morning.</li>     <li>\"Replacing two or more incumbent directors with diverse candidates experienced in effective human capital management should be the highest immediate priority for the company,\" said CtW executive director Dieter Waizenegger.</li>     <li>The view from Wall Street on Chipotle shifting away from the dual CEO model is mixed. Deutsche Bank doesn't see a timely turnaround for the restaurant chain, while Nomura ses a clear pivot from food safety to operations. Bullish-leaning SunTrust thinks Chipotle can improve its through-put (line speed) and customer satisfaction ratings under the new structure.</li>     <li>On Seeking Alpha, <a href=\"https://seekingalpha.com/article/4030153-chipotle-investment-yearning-normalize-earnings\" target=\"_blank\">Mitch Dol</a> weighs in. \"No doubt Chipotle is going through a temporary problem, and I'm betting it will recover to become one of the world's great restaurant chains,\" he writes.</li>     <li>Sources: Bloomberg and Reuters</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3229967-chipotle-names-ellis-sole-ceo\" target=\"_blank\">Chipotle names Ellis sole CEO</a> (Dec. 12)</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3229972-chipotle-founder-plans-make-simple\" target=\"_blank\">Chipotle founder plans to make it simple again</a> (Dec. 12)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3230294\" data-linked=\"Reactions to Chipotle&#39;s new look\" data-tweet=\"$CMG - Reactions to Chipotle&#39;s new look https://seekingalpha.com/news/3230294-reactions-to-chipotles-new-look?source=tweet\" data-url=\"https://seekingalpha.com/news/3230294-reactions-to-chipotles-new-look\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230289\" data-ts=\"1481644772\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNP\" target=\"_blank\">SNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230289-bloomberg-sinopec-eyes-takeover-of-gulf-keystone-petroleum\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Sinopec eyes takeover of Gulf Keystone Petroleum</a></h4><ul>     <li>Sinopec (<a href=\"https://seekingalpha.com/symbol/SNP\" title=\"China Petroleum &amp; Chemical Corporation\">SNP</a> <font color=\"green\">+2%</font>) is <a href=\"https://www.bloomberg.com/news/articles/2016-12-13/sinopec-said-to-weigh-takeover-of-kurdish-producer-gulf-keystone\" target=\"_blank\">considering a takeover</a> of Kurdistan-based oil producer Gulf Keystone Petroleum (<a href=\"https://seekingalpha.com/symbol/GUKYF\" title=\"GULF KEYSTONE PET ORD NEW\">OTCQX:GUKYF</a> <font color=\"green\">+3.6%</font>), Bloomberg reports.</li>     <li>Gulf Keystone is said to have been approached by the Chinese group, and may also attract other bidders.</li>     <li>Gulf Keystone was taken over by creditors in September after missing a bond payment and was forced to restructure its debt.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230289\" data-linked=\"Bloomberg: Sinopec eyes takeover of Gulf Keystone Petroleum\" data-tweet=\"$SNP $SNP $GUKYF - Bloomberg: Sinopec eyes takeover of Gulf Keystone Petroleum https://seekingalpha.com/news/3230289-bloomberg-sinopec-eyes-takeover-of-gulf-keystone-petroleum?source=tweet\" data-url=\"https://seekingalpha.com/news/3230289-bloomberg-sinopec-eyes-takeover-of-gulf-keystone-petroleum\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230267\" data-ts=\"1481644759\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230267-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/OPGN\" title=\"OpGen\">OPGN</a> <font color=\"green\">+63%</font>. <a href=\"https://seekingalpha.com/symbol/AKAO\" title=\"Achaogen\">AKAO</a> <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/DPRX\" title=\"Dipexium Pharmaceuticals, LLC\">DPRX</a> <font color=\"green\">+12%</font>. <a href=\"https://seekingalpha.com/symbol/ONVO\" title=\"Organovo Holdings, Inc.\">ONVO</a> <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/CERC\" title=\"Cerecor\">CERC</a> <font color=\"green\">+10%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/PRTO\" title=\"Proteon Therapeutics\">PRTO</a> <font color=\"red\">-74%</font>. APRI <font color=\"red\">-22%</font>. <a href=\"https://seekingalpha.com/symbol/LIFE\" title=\"aTyr Pharma\">LIFE</a> <font color=\"red\">-21%</font>. <a href=\"https://seekingalpha.com/symbol/AVXL\" title=\"Anavex Life Sciences Corp.\">AVXL</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/ATOS\" title=\"Atossa Genetics, Inc.\">ATOS</a> <font color=\"red\">-11%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230267\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$OPGN $AKAO $DPRX - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3230267-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3230267-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230285\" data-ts=\"1481643742\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMLS\" target=\"_blank\">CMLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230285-cumulus-media-launches-note-exchange-says-holders-participating\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cumulus Media launches note exchange, says most holders participating</a></h4><ul>   <li>Cumulus Media (<a href=\"https://seekingalpha.com/symbol/CMLS\" title=\"Cumulus Media Inc.\">CMLS</a> <font color=\"red\">-2.1%</font>) says most noteholders have agreed to participate in a private exchange offer it's launching in a refinancing support agreement.</li>    <li>The company launched a private exchange offer for any and all of its 7.75% senior notes due 2019, and holders of 57.3% of aggregate principal (about $349.7M) agreed to tender notes in the offer.</li>    <li>The company won't retain any cash proceeds and the notes will retired and canceled.</li>    <li>If 100% of principal is retired and canceled, former noteholders will hold about 33.3% of common equity and the company will have retired $610M in indebtedness (through the outstanding notes) and incurred $305M in indebtedness via revolving loans.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3230285\" data-linked=\"Cumulus Media launches note exchange, says most holders participating\" data-tweet=\"$CMLS - Cumulus Media launches note exchange, says most holders participating https://seekingalpha.com/news/3230285-cumulus-media-launches-note-exchange-says-holders-participating?source=tweet\" data-url=\"https://seekingalpha.com/news/3230285-cumulus-media-launches-note-exchange-says-holders-participating\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230283\" data-ts=\"1481643522\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LFVN\" target=\"_blank\">LFVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230283-lifevantage-f16-top-line-up-9-soft-guidance-sinks-shares-down-17\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lifevantage F16 top-line up 9%; soft guidance sinks shares, down 17%</a></h4><ul>\n<li>After the close yesterday, Lifevantage (<a href=\"https://seekingalpha.com/symbol/LFVN\" title=\"LifeVantage Corporation\">LFVN</a> <font color=\"red\">-16.5%</font>) reported fiscal 2016 revenue of $206.5M (+8.5%) and EPS of $0.41 (-16.1%). Non-GAAP EPS increased 31.8% to $0.62.</li>\n<li>Fiscal Q1 results (quarter ended September 30) were EPS of $0.08 (0%) on revenues of $54.9M (+21.0%).</li>\n<li>\n<strong>2017 Guidance</strong>: Revenue: $207M - 212M (+0 - 3%); Non-GAAP EPS: $0.40 - 0.47 (-35 - 24%).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230283\" data-linked=\"Lifevantage F16 top-line up 9%; soft guidance sinks shares, down 17%\" data-tweet=\"$LFVN - Lifevantage F16 top-line up 9%; soft guidance sinks shares, down 17% https://seekingalpha.com/news/3230283-lifevantage-f16-top-line-up-9-soft-guidance-sinks-shares-down-17?source=tweet\" data-url=\"https://seekingalpha.com/news/3230283-lifevantage-f16-top-line-up-9-soft-guidance-sinks-shares-down-17\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230281\" data-ts=\"1481643031\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIMX\" target=\"_blank\">HIMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230281-himax-technologies-downgraded-mizuho-securities\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Himax Technologies downgraded at Mizuho Securities</a></h4><ul>\n<li>Firm lowers rating from Buy to Neutral and target <a href=\"http://www.streetinsider.com/Analyst+PT+Change/Mizuho+Securities+Downgrades+Himax+Technologies+%28HIMX%29+to+Neutral/12337302.html\" target=\"_blank\">from $10 to $7.70</a> (current price $6.56).</li>\n<li>With a sharp downward move materializing early, share loss for Himax Technologies (NASDAQ:<a href=\"https://seekingalpha.com/symbol/HIMX\" title=\"Himax Technologies, Inc.\">HIMX</a>) is brought to a <font color=\"red\">roughly 11%</font> total on the week.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230281\" data-linked=\"Himax Technologies downgraded at Mizuho Securities\" data-tweet=\"$HIMX - Himax Technologies downgraded at Mizuho Securities https://seekingalpha.com/news/3230281-himax-technologies-downgraded-mizuho-securities?source=tweet\" data-url=\"https://seekingalpha.com/news/3230281-himax-technologies-downgraded-mizuho-securities\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230279\" data-ts=\"1481642723\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTZ\" target=\"_blank\">HTZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230279-hertz-spikes-off-of-icahn-rumor\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hertz spikes off of Icahn rumor</a></h4><ul> <li>Hertz Global (NYSE:<a href=\"https://seekingalpha.com/symbol/HTZ\" title=\"Hertz Global Holdings, Inc.\">HTZ</a>) sails higher amid M&amp;A speculation.</li> <li>The talk going around is that Icahn Enterprises (<a href=\"https://seekingalpha.com/symbol/IEP\" title=\"Icahn Enterprises L.P.\">IEP</a> <font color=\"red\">-0.8%</font>) is talking to other potential bidders for a run at Hertz.</li> <li>Shares of Hertz are <font color=\"green\">up 3.39%</font> to $23.50 on volume approaching 500K.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3230279\" data-linked=\"Hertz spikes off of Icahn rumor\" data-tweet=\"$HTZ $HTZ $IEP - Hertz spikes off of Icahn rumor https://seekingalpha.com/news/3230279-hertz-spikes-off-of-icahn-rumor?source=tweet\" data-url=\"https://seekingalpha.com/news/3230279-hertz-spikes-off-of-icahn-rumor\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230275\" data-ts=\"1481641438\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BRK.A\" target=\"_blank\">BRK.A</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230275-berkshire-hathaway-tops-250k-per-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Berkshire Hathaway tops $250K per share</a></h4><ul>     <li>Nearly 54 years ago to the day, <a href=\"http://blogs.wsj.com/moneybeat/2016/12/13/warren-buffetts-latest-milestone-berkshire-at-250000-per-share/\" target=\"_blank\">The Oracle put in his first buy order </a>for the textile maker, and paid $7.50 each for his initial 2K share stake.</li><li>A mere two years later, Warren Buffett was looking to exit his (then larger) position for $11.50 each, and thought he had a verbal agreement from Berkshire's owner for just that. When the formal written offer arrived at a few pennies less, a ticked-off Buffett instead began aggressively buying more.</li><li>The rest is history, and today the Class A shares of Berkshire (NYSE:<a href='https://seekingalpha.com/symbol/BRK.A' title='Berkshire Hathaway A'>BRK.A</a>) topped $250K for the first time ever.</li><li>Since the election, BRK is&nbsp;<font color='green'>higher by 13%</font>, about doubling the S&amp;P 500's performance. Year-to-date, BRK is&nbsp;<font color='green'>up 26.6%</font>&nbsp;vs. the S&amp;P's&nbsp;<font color='green'>11.6% advance</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3230275\" data-linked=\"Berkshire Hathaway tops $250K per share\" data-tweet=\"$BRK.A $BRK.B - Berkshire Hathaway tops $250K per share https://seekingalpha.com/news/3230275-berkshire-hathaway-tops-250k-per-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3230275-berkshire-hathaway-tops-250k-per-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230271\" data-ts=\"1481641109\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYNA\" target=\"_blank\">SYNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230271-synaptics-announces-new-fingerprint-sensors-new-oled-ddic-and-collaboration-oxi-technology\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synaptics announces new fingerprint sensors, new OLED DDIC and collaboration with OXi Technology</a></h4><ul>\n<li>Synaptics updates on a new suite of biometric authentication solutions enabling high-resolution fingerprint scanning through 1mm of full-cover glass, a new OLED DDIC offering to enhance display technologies and collaboration with OXi Technology to develop new proprietary optical sensing products for smartphones, tablets and PC devices.</li>\n<li>Shares (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SYNA\" title=\"Synaptics Incorporated\">SYNA</a>) are <font color=\"green\">up 1.9%</font> early.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230271\" data-linked=\"Synaptics announces new fingerprint sensors, new OLED DDIC and collaboration with OXi Technology\" data-tweet=\"$SYNA - Synaptics announces new fingerprint sensors, new OLED DDIC and collaboration with OXi Technology https://seekingalpha.com/news/3230271-synaptics-announces-new-fingerprint-sensors-new-oled-ddic-and-collaboration-oxi-technology?source=tweet\" data-url=\"https://seekingalpha.com/news/3230271-synaptics-announces-new-fingerprint-sensors-new-oled-ddic-and-collaboration-oxi-technology\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230264\" data-ts=\"1481640916\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DVA\" target=\"_blank\">DVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230264-baird-downgrades-davita-on-weak-expected-organic-growth-shares-slip-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baird downgrades DaVita on weak expected organic growth; shares slip 3%</a></h4><ul>\n<li>DaVita (<a href=\"https://seekingalpha.com/symbol/DVA\" title=\"DaVita HealthCare Partners Inc.\">DVA</a> <font color=\"red\">-2.5%</font>) stumbles out of the blocks this morning on the heels of a downgrade by Baird. Analyst Whit Mayo cut his rating to Neutral from Outperform but increased the price target to $69 (6% upside) from $68.</li>\n<li>He cites expectations of \"tepid organic growth\" unless the payer mix improves.</li>\n<li>In November, the company stopped supporting a charity that provided premium assistance for certain patients after CMS stated that Medicaid beneficiaries are not eligible for federal subsidies or premium credits. The company says the situation may affect ~2K of its dialysis patients who have extra coverage through an ADA plan. If CMS forbids charitable assistance for all dialysis patients on ACA plans, it would trim ~$230M off net income.</li>\n<li>Five shops still rate the stock a Buy with price targets ranging from $70 - 75.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230264\" data-linked=\"Baird downgrades DaVita on weak expected organic growth; shares slip 3%\" data-tweet=\"$DVA - Baird downgrades DaVita on weak expected organic growth; shares slip 3% https://seekingalpha.com/news/3230264-baird-downgrades-davita-on-weak-expected-organic-growth-shares-slip-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3230264-baird-downgrades-davita-on-weak-expected-organic-growth-shares-slip-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230269\" data-ts=\"1481640818\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230269-wells-fargo-t-mobile-purchase-might-cost-sprint-93_4b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wells Fargo: T-Mobile purchase might cost Sprint $93.4B</a></h4><ul>   <li>If a changing presidential administration finally makes for a Sprint/T-Mobile merger, it won't be cheap, says Wells Fargo's Jennifer Fritzsche.</li>    <li>Sprint (<a href=\"https://seekingalpha.com/symbol/S\" title=\"Sprint Corporation\">S</a> <font color=\"green\">+0.5%</font>) might have to open up its wallet <a href=\"http://www.fiercewireless.com/wireless/wells-fargo-sprint-could-acquire-t-mobile-for-93-4b\" target=\"_blank\">to the tune of $90B-plus</a> in such a deal, she writes -- which could mean that even in an amenable regulatory environment, the cost may be too high.</li>    <li>T-Mobile's (<a href=\"https://seekingalpha.com/symbol/TMUS\" title=\"T-Mobile US, Inc.\">TMUS</a> <font color=\"green\">+1.6%</font>) likely price is around $93.4B, she says, 8.5 times estimated EBITDA for fiscal 2017. That accounts for a 28% premium to T-Mobile equity and Sprint assuming $33B in T-Mobile net debt.</li>    <li>The two could save by cutting jobs and ad/marketing budgets along with consolidating billing systems, and line up spectrum portfolios in an optimal fashion. But even in Trumpworld there may be resistance to a three-carrier universe.</li>    <li>\u201cInterestingly, Sprint/T-Mobile would have more total subscribers than Verizon and nearly as many as AT&amp;T,\u201d Fritzsche says in her note. \u201cIn fact, this may be one of the largest impediments to a deal being approved\u2014the industry would become even more concentrated, with T-Mobile/Sprint having a dominant competitive position among \u2018value\u2019 postpaid and prepaid subscribers.\u201d</li> </ul><div class=\"tiny-share-widget\" data-id=\"3230269\" data-linked=\"Wells Fargo: T-Mobile purchase might cost Sprint $93.4B\" data-tweet=\"$S $S $TMUS - Wells Fargo: T-Mobile purchase might cost Sprint $93.4B https://seekingalpha.com/news/3230269-wells-fargo-t-mobile-purchase-might-cost-sprint-93_4b?source=tweet\" data-url=\"https://seekingalpha.com/news/3230269-wells-fargo-t-mobile-purchase-might-cost-sprint-93_4b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>83&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230263\" data-ts=\"1481639868\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SKYAY\" target=\"_blank\">SKYAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230263-pension-funds-agitate-on-price-in-likely-fox-sky-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pension funds agitate on price in likely Fox/Sky deal</a></h4><ul>   <li>Amid stirring for a higher price in what <a href=\"https://seekingalpha.com/news/3230116-reuters-fox-set-pursue-scheme-arrangement-bid-sky\" target=\"_blank\">looks like a friendly takeover</a> of Sky (<a href=\"https://seekingalpha.com/symbol/SKYAY\" title=\"Sky Plc ADR\">OTCPK:SKYAY</a>) by Twenty-First Century Fox (<a href=\"https://seekingalpha.com/symbol/FOX\" title=\"Twenty-First Century Fox, Inc.\">FOX</a> <font color=\"green\">+0.9%</font>, <a href=\"https://seekingalpha.com/symbol/FOXA\" title=\"Twenty-First Century Fox, Inc.\">FOXA</a> <font color=\"green\">+0.6%</font>), public sector pension funds in the UK are calling for <a href=\"http://www.reuters.com/article/us-sky-plc-m-a-twenty-first-fox-pensions-idUSKBN14217Y?feedType=nl&amp;feedName=innovationNews&amp;utm_source=Sailthru&amp;utm_medium=email&amp;utm_campaign=US%20Deals%20Today%202016-12-13&amp;utm_term=US%20Deals%20Today\" target=\"_blank\">an \"appropriate\" premium</a> and protections for minority shareholders.</li>    <li>\"All directors of Sky have a duty not to disadvantage the public shareholders, and the position of the non-executives will need to be robust to ensure that the premium paid is appropriate and that shareholders are not disadvantaged by any temporary low in the share price,\" says Kieran Quinn of the Local Authority Pension Fund Forum.</li>    <li>Quinn also called on regulator Ofcom to scrutinize the deal.</li>    <li>Fox looks to be closing in on a £10.75/share cash offer for Sky in a friendly setup via a scheme of arrangement, pointing to a cozy relationship between Sky and Fox, which already owns 39% of the broadcaster.</li>    <li>Sky is trading <font color=\"green\">up 1.7%</font> to 988.5 pence in London.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3230263\" data-linked=\"Pension funds agitate on price in likely Fox/Sky deal\" data-tweet=\"$SKYAY $SKYAY $FOX - Pension funds agitate on price in likely Fox/Sky deal https://seekingalpha.com/news/3230263-pension-funds-agitate-on-price-in-likely-fox-sky-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3230263-pension-funds-agitate-on-price-in-likely-fox-sky-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230255\" data-ts=\"1481639271\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYTR\" target=\"_blank\">CYTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230255-cytrx-announces-direct-equity-offering-shares-down-21-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CytRx announces direct equity offering; shares down 21% premarket</a></h4><ul>\n<li>CytRx (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CYTR\" title=\"CytRx Corporation\">CYTR</a>) is off <font color=\"red\">21%</font> premarket on robust volume in response to its announcement of an $8.1M direct offering of common stock at $0.42 a share. Closing date is December 16.</li>\n<li>Net proceeds of ~$7.4M will fund working capital and general corporate purposes.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230255\" data-linked=\"CytRx announces direct equity offering; shares down 21% premarket\" data-tweet=\"$CYTR - CytRx announces direct equity offering; shares down 21% premarket https://seekingalpha.com/news/3230255-cytrx-announces-direct-equity-offering-shares-down-21-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3230255-cytrx-announces-direct-equity-offering-shares-down-21-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230250\" data-ts=\"1481638745\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230250-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul>\n<li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/NVCN\" title=\"Neovasc Inc.\">NVCN</a> <font color=\"green\">+26%</font>. <a href=\"https://seekingalpha.com/symbol/OPGN\" title=\"OpGen\">OPGN</a> <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/AKAO\" title=\"Achaogen\">AKAO</a> <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/VNR\" title=\"Vanguard Natural Resources, LLC\">VNR</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/AUPH\" title=\"Aurinia Pharmaceuticals Inc.\">AUPH</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/CIE\" title=\"Cobalt International Energy, Inc.\">CIE</a> <font color=\"green\">+6%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/PRTO\" title=\"Proteon Therapeutics\">PRTO</a> <font color=\"red\">-69%</font>. <a href=\"https://seekingalpha.com/symbol/INOV\" title=\"Inovalon\">INOV</a> <font color=\"red\">-37%</font>. <a href=\"https://seekingalpha.com/symbol/BDSI\" title=\"BioDelivery Sciences International, Inc.\">BDSI</a> <font color=\"red\">-18%</font>. <a href=\"https://seekingalpha.com/symbol/ELGX\" title=\"Endologix Inc\">ELGX</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/PEIX\" title=\"Pacific Ethanol, Inc.\">PEIX</a> <font color=\"red\">-6%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230250\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$NVCN $OPGN $AKAO - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3230250-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3230250-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230241\" data-ts=\"1481638059\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HXL\" target=\"_blank\">HXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230241-hexcel-guides-2017-earnings-revenues-below-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hexcel guides 2017 earnings, revenues below consensus</a></h4><ul>     <li>Hexcel (NYSE:<a href=\"https://seekingalpha.com/symbol/HXL\" title=\"Hexcel Corporation\">HXL</a>) <font color=\"red\">-2.3%</font> premarket after issuing downside guidance for FY 2017, even amid \"another record year of sales and earnings, strong operating income margin, and generation of free cash flow.\"</li>     <li>HXL sees 2017 EPS of $2.64-$2.76 vs. $2.80 analyst consensus estimate, on revenues of of $2.05B-$2.15B vs. $2.16B consensus.</li>\n<li>For its commercial aerospace business, which comprises 71% of  sales, HXL expects sales growth in the mid-single digit  percentage range in 2017.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3230241\" data-linked=\"Hexcel guides 2017 earnings, revenues below consensus\" data-tweet=\"$HXL - Hexcel guides 2017 earnings, revenues below consensus https://seekingalpha.com/news/3230241-hexcel-guides-2017-earnings-revenues-below-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3230241-hexcel-guides-2017-earnings-revenues-below-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230233\" data-ts=\"1481637632\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AUPH\" target=\"_blank\">AUPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230233-aurinia-pharma-on-go-single-pivotal-study-to-support-voclosporin-marketing-application-for\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aurinia Pharma on go with single pivotal study to support voclosporin marketing application for lupus nephritis; shares ahead 10% premarket</a></h4><ul>\n<li>Aurinia Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AUPH\" title=\"Aurinia Pharmaceuticals Inc.\">AUPH</a>) is up <font color=\"green\">10%</font> premarket on increased volume in response to its announcement that its will be launching a single Phase 3 study, AURORA, that will support a New Drug Application (NDA) in the U.S. seeking approval of lead product candidate voclosporin for the treatment of lupus nephritis, a Fast Track indication. Just-received minutes from its end-of-Phase 2 meeting with the agency back the plan and are consistent with earlier verbal feedback.</li>\n<li>Enrollment in the 320-subject, 52-week AURORA study should commence in Q2 2017. The primary endpoint is the same as the Phase 2b AURA trial: renal response (complete remission) at week 24. Secondary endpoints include the duration of response at 52 weeks.</li>\n<li>\n<a href=\"http://www.auriniapharma.com/dnn/ProductsInDevelopment/Voclosporin/WhatisVoclosporin.aspx\" target=\"_blank\">Voclosporin </a>suppresses the immune system by inhibiting an enzyme called <a href=\"https://en.wikipedia.org/wiki/Calcineurin\" target=\"_blank\">calcineurin</a>, which activates T cells. Its value proposition is similar effectiveness to other calcineurin inhibitors (cyclosporin and tacrolimus) without the deleterious side effects.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230233\" data-linked=\"Aurinia Pharma on go with single pivotal study to support voclosporin marketing application for lupus nephritis; shares ahead 10% premarket\" data-tweet=\"$AUPH - Aurinia Pharma on go with single pivotal study to support voclosporin marketing application for lupus nephritis; shares ahead 10% premarket https://seekingalpha.com/news/3230233-aurinia-pharma-on-go-single-pivotal-study-to-support-voclosporin-marketing-application-for?source=tweet\" data-url=\"https://seekingalpha.com/news/3230233-aurinia-pharma-on-go-single-pivotal-study-to-support-voclosporin-marketing-application-for\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230232\" data-ts=\"1481637522\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KO\" target=\"_blank\">KO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230232-coca-cola-taken-down-notch-deutsche-bank\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coca-Cola taken down a notch by Deutsche Bank</a></h4><ul> <li>Deutsche Bank lowers its rating on Coca-Cola (NYSE:<a href=\"https://seekingalpha.com/symbol/KO\" title=\"The Coca-Cola Company\">KO</a>) to Hold from Buy.</li> <li>The investment firm warns on the risk of downward earnings revisisions and sees pressure from macro factors such as higher interest rates and F/X.</li> <li>DB <a href=\"http://www.cnbc.com/2016/12/13/early-movers-ba-pay-dgx-lly-fitb-googl-more.html\" target=\"_blank\">cuts</a> its price target on Coca-Cola to $44 from $48.</li>\n<li>Earlier, Deutsche downgraded hit fellow Dow 30 stock Procter &amp; Gamble with a downgrade.</li> <li>Shares of Coca-Cola are <font color=\"red\">down 0.48%</font> to $41.70 vs. a 52-week trading range of $39.88 to $47.13.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3230206-deutsche-bank-cools-procter-and-gamble\" target=\"_blank\">Deutsche Bank cools off on Procter &amp; Gamble</a> (Dec. 13)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3230232\" data-linked=\"Coca-Cola taken down a notch by Deutsche Bank\" data-tweet=\"$KO - Coca-Cola taken down a notch by Deutsche Bank https://seekingalpha.com/news/3230232-coca-cola-taken-down-notch-deutsche-bank?source=tweet\" data-url=\"https://seekingalpha.com/news/3230232-coca-cola-taken-down-notch-deutsche-bank\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230227\" data-ts=\"1481637168\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STAY\" target=\"_blank\">STAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230227-extended-stay-america-announces-pricing-of-paired-secondary-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Extended Stay America announces pricing of paired secondary offering</a></h4><ul> <li>Extended Stay America (NYSE:<a href=\"https://seekingalpha.com/symbol/STAY\" title=\"Extended Stay America, Inc.\">STAY</a>) announces the pricing of the       underwritten secondary offering of 12.5M paired shares (Extended Stay America share + a class B share of ESH       Hospitality) at a gross proceeds level of ~$20.25M.</li>\n<li>The offering is       expected to close on December 16.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3230112-extended-stay-backers-cash-shares\" target=\"_blank\">Extended Stay backers cash in some shares</a> (Dec. 12)</li>     <li>STAY  <font color=\"red\">-3.03%</font> premarket to  $16.31.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230227\" data-linked=\"Extended Stay America announces pricing of paired secondary offering\" data-tweet=\"$STAY - Extended Stay America announces pricing of paired secondary offering https://seekingalpha.com/news/3230227-extended-stay-america-announces-pricing-of-paired-secondary-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3230227-extended-stay-america-announces-pricing-of-paired-secondary-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230222\" data-ts=\"1481636886\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HBHC\" target=\"_blank\">HBHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230222-hancock-holdingminus-3_4-after-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hancock Holding -3.4% after capital raise</a></h4><ul>\n<li>The Mississippi-based bank holding company is selling 5M shares, with an underwriter greenshoe of 750K shares.</li>\n<li>The timing is good - after<font color=\"green\"> a 75% run higher </font>in 2016, the stock's at its highest level since 2008/09.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/HBHC\" title=\"Hancock Holding Company\">HBHC</a><font color=\"red\"> -3.4%</font> premarket to $42.50.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230222\" data-linked=\"Hancock Holding -3.4% after capital raise\" data-tweet=\"$HBHC - Hancock Holding -3.4% after capital raise https://seekingalpha.com/news/3230222-hancock-holdingminus-3_4-after-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3230222-hancock-holdingminus-3_4-after-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230206\" data-ts=\"1481635853\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PG\" target=\"_blank\">PG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230206-deutsche-bank-cools-off-on-procter-gamble\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank cools off on Procter &amp; Gamble</a></h4><ul> <li>Deutsche Bank <a href=\"http://www.cnbc.com/2016/12/13/early-movers-ba-pay-dgx-lly-fitb-googl-more.html\" target=\"_blank\">cuts</a> Procter &amp; Gamble (NYSE:<a href=\"https://seekingalpha.com/symbol/PG\" title=\"The Procter &amp; Gamble Company\">PG</a>) to a Hold rating from Buy.</li> <li>The investment firm cites broad concerns on P&amp;G such as higher interest rates, a strong USD and a lack of near-term catalysts.</li> <li>DB slides its PT to $90 from $95, although it still likes the long-term story on the staples stock.</li> <li>PG <font color=\"red\">-0.29%</font> premarket to $84.88 vs. a 52-week trading range of $74.46 to $90.33.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3230206\" data-linked=\"Deutsche Bank cools off on Procter &amp; Gamble\" data-tweet=\"$PG - Deutsche Bank cools off on Procter &amp; Gamble https://seekingalpha.com/news/3230206-deutsche-bank-cools-off-on-procter-gamble?source=tweet\" data-url=\"https://seekingalpha.com/news/3230206-deutsche-bank-cools-off-on-procter-gamble\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230204\" data-ts=\"1481635508\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELGX\" target=\"_blank\">ELGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230204-regulators-pull-ce-mark-from-endologixs-afx-system-shares-down-10-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Regulators pull CE Mark from Endologix&#39;s AFX system; shares down 10% premarket</a></h4><ul>\n<li>Endologix (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ELGX\" title=\"Endologix Inc\">ELGX</a>) slips <font color=\"red\">10%</font> premarket on modest volume in response to its <a href=\"https://www.sec.gov/Archives/edgar/data/1013606/000119312516791340/d303943d8k.htm\" target=\"_blank\">disclosure</a> that the Notified Body in the European Union has notified it that it is suspending CE Mark certification for its <a href=\"https://endologix.com/united-states/products/afx/\" target=\"_blank\">AFX system</a> due to reports of Type III (device separation) endoleaks with a earlier generation of the device.</li>\n<li>The company says its has implemented device and graft material improvements and updated instructions for use that have substantially reduced reported Type III endoleaks. No reports of Type III endoleaks have been reported with its next generation AFX2 product.</li>\n<li>Management expects CE Mark certification to be reinstated next month.</li>\n<li>AFX and AFX2 remain available in the U.S., Japan and other international markets. They are used to repair an abdominal aortic aneurysm.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230204\" data-linked=\"Regulators pull CE Mark from Endologix&#39;s AFX system; shares down 10% premarket\" data-tweet=\"$ELGX - Regulators pull CE Mark from Endologix&#39;s AFX system; shares down 10% premarket https://seekingalpha.com/news/3230204-regulators-pull-ce-mark-from-endologixs-afx-system-shares-down-10-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3230204-regulators-pull-ce-mark-from-endologixs-afx-system-shares-down-10-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230200\" data-ts=\"1481634838\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARI\" target=\"_blank\">ARI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230200-apollo-commercial-down-4_75-after-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apollo Commercial down 4.75% after capital raise</a></h4><ul>\n<li>Apollo Commercial Real Estate Finance (NYSE:<a href=\"https://seekingalpha.com/symbol/ARI\" title=\"Apollo Commercial Real Estate Finance, Inc.\">ARI</a>) sold 10.5M shares in a secondary offering for estimated gross proceeds of $180M, suggesting a price of about $17.14 each. The underwriters have an option to buy another 1.575M shares at that price.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/ARI\" title=\"Apollo Commercial Real Estate Finance, Inc.\">ARI</a> <font color=\"red\">-4.75%</font> premarket to $17.01.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230200\" data-linked=\"Apollo Commercial down 4.75% after capital raise\" data-tweet=\"$ARI - Apollo Commercial down 4.75% after capital raise https://seekingalpha.com/news/3230200-apollo-commercial-down-4_75-after-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3230200-apollo-commercial-down-4_75-after-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230184\" data-ts=\"1481633407\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BWLD\" target=\"_blank\">BWLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230184-buffalo-wild-wings-on-watch-after-bmo-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buffalo Wild Wings on watch after BMO cut</a></h4><ul> <li>BMO Capital lowers Buffalo Wild Wings (<a href=\"https://seekingalpha.com/symbol/BWLD\" title=\"Buffalo Wild Wings, Inc.\">BWLD</a>) to a Market Perform <a href=\"https://www.marketbeat.com/stocks/NASDAQ/BWLD/\" target=\"_blank\">rating</a> on concerns over valuation and the risk of missing 2017 EPS estimates.</li> <li>The restaurant stock was rated by BMO at Outperform previously.</li> <li>The investment firm drops its price target by $5 to $185, a PT that factors in the strategic initiatives announced by BWLD management.</li> <li>Buffalo Wild Wings <font color=\"red\">-1.00%</font> premarket to $172.50.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3230184\" data-linked=\"Buffalo Wild Wings on watch after BMO cut\" data-tweet=\"$BWLD - Buffalo Wild Wings on watch after BMO cut https://seekingalpha.com/news/3230184-buffalo-wild-wings-on-watch-after-bmo-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3230184-buffalo-wild-wings-on-watch-after-bmo-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230183\" data-ts=\"1481633162\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BDSI\" target=\"_blank\">BDSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230183-biodeliverys-clonidine-topical-gel-flunks-mid-stage-study-in-diabetic-neuropathy-shares-drop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioDelivery&#39;s Clonidine Topical Gel flunks mid-stage study in diabetic neuropathy; shares drop 30% premarket</a></h4><ul>\n<li>BioDelivery Sciences International's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/BDSI\" title=\"BioDelivery Sciences International, Inc.\">BDSI</a>) <a href=\"http://www.bdsi.com/Topical_Clonidine_Gel.aspx\" target=\"_blank\">Clonidine Topical Gel </a>failed to beat placebo in a Phase 2b clinical trial assessing the product for the management of diabetic neuropathy. The company says it will discontinue further development at this time.</li>\n<li>In March 2015, the company reported failed results from a late-stage study for the same indication.</li>\n<li>Shares are down <font color=\"red\">30%</font> premarket on light volume.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2397816-biodelivery-sciences-clonidine-topical-gel-fails-phase-3-shares-plunge-35-percent\" target=\"_blank\">BioDelivery Sciences' Clonidine Topical Gel fails Phase 3; shares plunge 35%</a> (March 30, 2015)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230183\" data-linked=\"BioDelivery&#39;s Clonidine Topical Gel flunks mid-stage study in diabetic neuropathy; shares drop 30% premarket\" data-tweet=\"$BDSI - BioDelivery&#39;s Clonidine Topical Gel flunks mid-stage study in diabetic neuropathy; shares drop 30% premarket https://seekingalpha.com/news/3230183-biodeliverys-clonidine-topical-gel-flunks-mid-stage-study-in-diabetic-neuropathy-shares-drop?source=tweet\" data-url=\"https://seekingalpha.com/news/3230183-biodeliverys-clonidine-topical-gel-flunks-mid-stage-study-in-diabetic-neuropathy-shares-drop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230179\" data-ts=\"1481632523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRTO\" target=\"_blank\">PRTO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230179-proteons-lead-product-candidate-flunks-late-stage-study-in-chronic-kidney-disease-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Proteon&#39;s lead product candidate flunks late-stage study in chronic kidney disease; shares plummet 73% premarket</a></h4><ul>\n<li>A Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02110901?term=vonapanitase&amp;rank=4\" target=\"_blank\">PATENCY-1</a>, assessing Proteon Therapeutics' (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PRTO\" title=\"Proteon Therapeutics\">PRTO</a>) lead product candidate vonapanitase in patients with chronic kidney disease (CKD) failed to achieve its primary endpoint of improved unassisted patency compared to placebo (p=0.254).</li>\n<li>The primary endpoint was primary unassisted patency defined as the length of time from fistula surgical creation to the firs occurrence of a fistula thrombosis (blood clot) or corrective procedure to restore/maintain patency (blood flow). Results showed patients receiving vonapanitase experienced a 17% reduction in the risk of primary unassisted patency loss over one year versus placebo. At the end of one year, 42% of vonapanitase-treated patients retained primary unassisted patency compared to 31% for placebo.</li>\n<li>The company says data from the secondary endpoint and one of the tertiary endpoints offer some hope that vonapanitase may be effective by other criteria.</li>\n<li>Fast Track- and Orphan Drug-designated <a href=\"http://www.proteontherapeutics.com/docs/Publication%20Dixon%20et%20al%202015%20NKF%20Poster.pdf\" target=\"_blank\">vonapanitase </a>is a recombinant human <a href=\"https://en.wikipedia.org/wiki/Elastase\" target=\"_blank\">elastase</a>, an enzyme that breaks down <a href=\"https://en.wikipedia.org/wiki/Elastin\" target=\"_blank\">elastin</a>, an elastic fiber that, together with collagen, determines the structure of connective tissue.</li>\n<li>Management will host a conference call this morning at 8?30 am ET to discuss the results.</li>\n<li>Shares are down <font color=\"red\">73%</font> premarket on light volume.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230179\" data-linked=\"Proteon&#39;s lead product candidate flunks late-stage study in chronic kidney disease; shares plummet 73% premarket\" data-tweet=\"$PRTO - Proteon&#39;s lead product candidate flunks late-stage study in chronic kidney disease; shares plummet 73% premarket https://seekingalpha.com/news/3230179-proteons-lead-product-candidate-flunks-late-stage-study-in-chronic-kidney-disease-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3230179-proteons-lead-product-candidate-flunks-late-stage-study-in-chronic-kidney-disease-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3230166\" data-ts=\"1481630412\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNGX\" target=\"_blank\">SNGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3230166-soligenix-prices-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Soligenix prices equity offering</a></h4><ul>\n<li>Soligenix (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SNGX\" title=\"Soligenix, Inc.\">SNGX</a>) prices its public offering of 1.67M shares of common stock and warrants to purchase up to 2,087,500 shares of common at a combined price of $3.16. The five-year warrants are exercisable at $3.95 per common share. Underwriters over-allotment is an additional 250,500 shares and/or 313,125 additional warrants. Closing date is December 16.</li>\n<li>Yesterday's close was $3.47.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3230166\" data-linked=\"Soligenix prices equity offering\" data-tweet=\"$SNGX - Soligenix prices equity offering https://seekingalpha.com/news/3230166-soligenix-prices-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3230166-soligenix-prices-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:00 AM </div></div></li>","count":56,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}